For example, in models of breast cancer, CCR2+ monocytes are the main source of TAMs, accounting for approximately 40% of all CD45+ cells within tumor tissues, compared to less than 10% derived from TRMs (26). This evidence concerns the gene CCR2 and neoplasm.